What to Know About JN.1, the Latest Omicron Variant
Vaccines, tests, and antivirals are still effective tools in the latest COVID surge. In early November 2023, the JN.1 variant caused less than 5% of COVID-19 cases in the U.S. Now it is estimated to cause more than 60% of them. Virologists including Andy Pekosz, PhD, a professor in Molecular Microbiology and Immunology, are paying attention. Here, Pekosz […]